Clozapine use in childhood and adolescent schizophrenia: A nationwide population-based study

European Neuropsychopharmacology

Volumn 25, Issue 6, 2015, Pages 857-863

  Schneider, Carolina ^a   Papachristou, Efstathios ^b   Wimberley, Theresa ^c   Gasse, Christiane ^c   Dima, Danai ^d,e   MacCabe, James H ^a   Mortensen, Preben Bo ^c   Frangou, Sophia ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c AARHUS UNIVERSITY   (Denmark)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Antipsychotic; Children; Clozapine; Denmark; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADOLESCENT; ARTICLE; CANNABIS ADDICTION; CLINICAL FEATURE; DISEASE DURATION; EARLY ONSET SCHIZOPHRENIA; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FAMILY HISTORY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENTAL DEPRIVATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SUICIDE ATTEMPT; TREATMENT RESPONSE; URBANIZATION; CHILD; DENMARK; EPIDEMIOLOGY; HEALTH CARE PLANNING; PRESCRIPTION; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; CLOZAPINE; COMMUNITY HEALTH PLANNING; DENMARK; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; REGISTRIES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930276149     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.02.003     Document Type: Article

References (38)

1. Addington AM, Rapoport JL The genetics of childhood-onset schizophrenia: when madness strikes the prepubescent. Curr. Psychiatry Rep. 2009, 11:156-161.
2. Ahn K, Gotay N, Andersen TM, Anvari AA, Gochman P, Lee Y, Sanders S, Guha S, Darvasi A, Glessner JT, Hakonarson H, Lencz T, State MW, Shugart YY, Rapoport JL High rate of disease-related copy number variations in childhood onset schizophrenia. Mol. Psychiatry 2013, 19:568-572.
3. Cannon M, Jones P, Huttunen MO, Tanskanen A, Huttunen T, Rabe-Hesketh S, Murray RM School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch. Gen. Psychiatry 1999, 56:457-463.
4. Cirulli G Clozapine prescribing in adolescent psychiatry: survey of prescribing practice in in-patient units. Psychiatr. Bull. 2005, 29:377-380.
5. Falcone T, Mishra L, Carlton E, Lee C, Butler RS, Janigro D, Simon B, Franco K Suicidal behavior in adolescents with first-episode psychosis. Clin. Schizophr. Relat. Psychoses 2010, 4:34-40.
6. Findling RL, Johnson JL, McClellan J, Frazier JA, Vitiello B, Hamer RM, Lieberman JA, Ritz L, McNamara NK, Lingler J, Hlastala S, Pierson L, Puglia M, Maloney AE, Kaufman EM, Noyes N, Sikich L. Double-blind maintenance safety and effectiveness findings from the treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study. J. Am. Acad. Child Adolesc. Psychiatry 2010, 49:583-594.
7. Gochman P, Miller R, Rapoport JL Childhood-onset schizophrenia: the challenge of diagnosis. Curr. Psychiatry Rep. 2011, 13:321-322.
8. Harrison J, Janlöv M, Wheeler AJ Patterns of clozapine prescribing in a mental health service in New Zealand. Pharm. World Sci. 2010, 32:503-511.
9. Heinz A, Deserno L, Reininghaus U Urbanicity, social adversity and psychosis. World Psychiatry 2013, 12:187-197.
10. Howes OD, Vergunst F, Gee S, McGuire P, Kapur S, Taylor D Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br. J. Psychiatry 2012, 201:481-485.
11. Jarbin H, Von Knorring AL Suicide and suicide attempts in adolescent-onset psychotic disorders. Nord. J. Psychiatry 2004, 58:115-123.
12. Kildemoes HW, Sørensen HT, Hallas J The Danish National Prescription Registry. Scand. J. Public Health 2011, 39(7 Suppl.):S38-S41.
13. Kuepper R, van Os J, Lieb R, Wittchen HU, Henquet C Do cannabis and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort study. Psychol. Med. 2011, 41:2121-2129.
14. Kumra S, Thaden E, DeThomas C, Kranzler H Correlates of substance abuse in adolescents with treatment-refractory schizophrenia and schizoaffective disorder. Schizophr. Res. 2005, 73:369-371.
15. Large M, Sharma S, Compton MT, Slade T, Nielssen O Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch. Gen. Psychiatry 2011, 68:555-561.
16. McClellan J, Stock S Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J. Am. Acad. Child Adolesc. Psychiatry 2013, 52:976-990. American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI).
17. Meltzer HY Clozapine: balancing safety with superior antipsychotic efficacy. Clin. Schizophr. Relat. Psychoses 2012, 6:134-144.
18. Mors O, Perto GP, Mortensen PB The Danish psychiatric central research registers. Scand. J. Public Health 2011, 39:54-57.
19. Munk-Jørgensen P, Østergaard SD Register-based studies of mental disorders. Scand. J. Public Health 2011, 39:170-174.
20. National Institute for Health and Clinical Excellence (NICE) Psychosis and Schizophrenia in Children and Young People, Recognition and Management 2013, NICE, London.
21. Pedersen CB, Gøtzsche H, Møller JØ, Mortensen PB The Danish civil registration system. Dan. Med. Bull. 2006, 53:441-449.
22. Nielsen J, Nielsen RE, Correll CU Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish register study. J. Clin. Psychopharmacol. 2012, 32:678-683.
23. Rapoport JL, Addington AM, Frangou S The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 2005, 10:434-449.
24. Remschmidt H, Martin M, Fleischhaker C, Theisen FM, Hennighausen K, Gutenbrunner C, Schulz E Forty-two-years later: the outcome of childhood-onset schizophrenia. J Neural Transm. 2007, 114:505-512.
25. Röpcke B, Eggers C Early-onset schizophrenia: a 15-year follow-up. Eur. Child Adolesc. Psychiatry 2005, 14:341-350.
26. Sanchez-Gistau V, Baeza I, Arango C, González-Pinto A, de la Serna E, Parellada M, Graell M, Paya B, Llorente C, Castro-Fornieles J Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study. J. Clin. Psychiatry 2013, 74:59-66.
27. Schimmelmann BG, Conus P, Cotton S, McGorry PD, Lambert M Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr. Res. 2007, 95:1-8.
28. Schimmelmann BG, Conus P, Cotton S, Kupferschmid S, McGorry PD, Lambert M Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. Eur. Psychiatry 2012, 27:463-469.
29. Schneider C, Corrigall R, Hayes D, Kyriakopoulos M, Frangou S Systematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophrenia. Eur. Psychiatry 2014, 29:1-10.
30. Shoval G, Sever J, Sher L, Diller R, Apter A, Weizman A, Zalsman G Substance use, suicidality, and adolescent-onset schizophrenia: an Israeli 10-year retrospective study. J. Child Adolesc. Psychopharmacol. 2006, 16:767-775.
31. Sikich L, Frazier JA, McClellan J, Findling RL, Vitiello B, Ritz L, Ambler D, Puglia M, Maloney AE, Michael E, De Jong S, Slifka K, Noyes N, Hlastala S, Pierson L, McNamara NK, Delporto-Bedoya D, Anderson R, Hamer RM, Lieberman JA Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am. J. Psychiatry 2008, 165:1420-1431.
32. Stroup TS, Gerhard T, Crystal S, Huang C, Olfson M Geographic and clinical variation in clozapine use in the United States. Psychiatr. Serv. 2014, 65:186-192.
33. Uggerby P, Nielsen RE, Correll CU, Nielsen J Characteristics and predictors of long-term institutionalization in patients with schizophrenia. Schizophr. Res. 2011, 131:120-126.
34. Vourdas A, Pipe R, Corrigall R, Frangou S Increased developmental deviance and premorbid dysfunction in early onset schizophrenia. Schizophr. Res. 2003, 62:13-22.
35. Vyas NS, Hadjulis M, Vourdas A, Byrne P, Frangou S The Maudsley early onset schizophrenia study. Predictors of psychosocial outcome at 4-year follow-up. Eur. Child Adolesc. Psychiatry 2007, 16:465-470.
36. World Health Organization (WHO) The International Classification of Diseases 1967, WHO, Geneva, 8th revision (ICD-8).
37. World Health Organization (WHO), The ICD-10 classification of mental and behavioral disorders, in: Clinical Descriptions and Diagnostic Guidelines, WHO, Geneva, 1992.
38. World Health Organisation Collaborating Centre for Drug Statistics Methodology (WHOCC) Defined Daily Dose (DDD) Definition and General Considerations 2009, WHOCC, Oslo. http://www.whocc.no/ddd/definition_and_general_considera/.